Cellular cysteine-containing proteins

Cellular cysteine-containing proteins encompass the entire set of proteins within a cell that contain the amino acid cysteine, often referred to as the cysteine proteome. Cysteine is distinguished by its reactive thiol (-SH) group, which is essential for the formation of disulfide bonds that stabilize protein structures, the coordination of metal ions in structural motifs like zinc fingers, and the execution of catalytic functions in various enzymes (Metallomics, 2018). In pharmacology, these proteins are critical because the nucleophilic nature of the cysteine thiol makes them prime targets for covalent drugs and electrophilic compounds. While many modern therapeutic agents are designed to selectively target a single cysteine residue in a specific protein, such as the kinase domain of EGFR or BTK, they often exhibit off-target reactivity with other cellular cysteine-containing proteins, which can lead to unintended side effects or toxicity (Cole et al., 2018). Conversely, some drugs like arsenic trioxide and dimethyl fumarate exert their effects by interacting with multiple cysteine-containing proteins to modulate redox signaling or induce the degradation of specific oncogenic factors (ResearchGate, 2021). Furthermore, the non-specific binding of reactive drug metabolites, such as NAPQI from acetaminophen, to these proteins is a well-known mechanism of organ-specific toxicity. Understanding the global reactivity of cellular cysteine-containing proteins is therefore vital for both drug design and the assessment of therapeutic safety.

Other names

Cysteine proteomeThiol-containing proteinsCysteine-rich proteins

Covalent modification of cysteine thiol groups, leading to enzyme inhibition, protein degradation, or modulation of redox-sensitive signaling pathways.